Why Cognizant (CTSH) is a Top Growth Stock for the Long-Term

Cognizant (CTSH) is rated Zacks Rank #3 (Hold) but carries an A VGM score and B Growth score, with current-fiscal-year earnings projected to rise 8.1% year over year. Seven analysts increased their fiscal 2026 estimates over the past 60 days, lifting consensus EPS by $0.01 to $5.71; Cognizant's average earnings surprise is +3.6%. The article presents a favorable long-term growth-screening case, though it contains no new company-reported operational or financial event likely to materially move shares.

Analysis

The estimate-revision signal is directionally constructive but economically immaterial: a $0.01 change to out-year EPS is not enough to support a durable multiple rerating in a large-cap IT-services name. The relevant 1-3 month catalyst is whether Cognizant converts AI/modernization bookings into accelerating revenue growth without sacrificing utilization or pricing; absent that evidence, the stock will trade with the broader enterprise-spending and rate-sensitive services basket rather than on this screening signal.

Competitive dynamics are mixed. CTSH can benefit as clients consolidate legacy application work and fund cloud/data/AI projects, but those same projects reduce labor-intensive maintenance demand over a 6-18 month horizon and intensify competition from ACN, EPAM and GLOB. The non-obvious risk is that generative-AI productivity gains are first captured by customers through lower billable headcount and fixed-price renegotiations, compressing offshore-services margins before vendors can reprice outcomes-based work. A sustained improvement in bookings, utilization and deal pricing would falsify that margin-risk thesis; another quarter of low-single-digit growth or reduced margin guidance would confirm it.

This is routine promotional research rather than an independently actionable fundamental development. The modestly favorable sentiment may generate limited retail attention, but institutional positioning should be determined by quarterly bookings, large-deal TCV, discretionary-spending commentary and the pace of consensus FY27 revisions—not style-score designations or historical backtests.

Key Decisions for Investors

• No standalone CTSH trade on this article; place CTSH on an earnings watchlist for the next 1-3 months and require evidence of accelerating constant-currency revenue growth plus stable-to-higher operating-margin guidance before adding exposure.
• Use a relative-value framework rather than outright beta: consider long CTSH / short EPAM only if CTSH demonstrates improving large-deal conversion while EPAM continues to face Europe-weighted discretionary-demand pressure. Target a 5-8% relative move over one quarter; exit if CTSH bookings or utilization deteriorate.
• For existing CTSH longs, trim or hedge against ACN if management signals that AI delivery productivity is being passed through in pricing faster than it is monetized in volume. The key falsifier is a downward revision to operating-margin outlook or evidence of fixed-price contract pressure.
• Monitor the magnitude and breadth of estimate changes: upgrade the thesis only if FY26-FY27 consensus EPS rises by at least 3-5% across multiple analysts and is accompanied by revenue—not merely cost-control—drivers.